These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 19605472)
1. Molecular mechanism of BST2/tetherin downregulation by K5/MIR2 of Kaposi's sarcoma-associated herpesvirus. Mansouri M; Viswanathan K; Douglas JL; Hines J; Gustin J; Moses AV; Früh K J Virol; 2009 Oct; 83(19):9672-81. PubMed ID: 19605472 [TBL] [Abstract][Full Text] [Related]
2. The RING-CH ligase K5 antagonizes restriction of KSHV and HIV-1 particle release by mediating ubiquitin-dependent endosomal degradation of tetherin. Pardieu C; Vigan R; Wilson SJ; Calvi A; Zang T; Bieniasz P; Kellam P; Towers GJ; Neil SJ PLoS Pathog; 2010 Apr; 6(4):e1000843. PubMed ID: 20419159 [TBL] [Abstract][Full Text] [Related]
3. Kaposi's sarcoma-associated herpesvirus ubiquitin ligases downregulate cell surface expression of l-selectin. Kajikawa M; Imaizumi N; Machii S; Nakamura T; Harigane N; Kimura M; Miyano K; Ishido S; Kanamoto T J Gen Virol; 2021 Nov; 102(11):. PubMed ID: 34726593 [TBL] [Abstract][Full Text] [Related]
4. Quantitative membrane proteomics reveals new cellular targets of viral immune modulators. Bartee E; McCormack A; Früh K PLoS Pathog; 2006 Oct; 2(10):e107. PubMed ID: 17238276 [TBL] [Abstract][Full Text] [Related]
5. Kaposi's sarcoma-associated herpesvirus K3 and K5 ubiquitin E3 ligases have stage-specific immune evasion roles during lytic replication. Brulois K; Toth Z; Wong LY; Feng P; Gao SJ; Ensser A; Jung JU J Virol; 2014 Aug; 88(16):9335-49. PubMed ID: 24899205 [TBL] [Abstract][Full Text] [Related]
6. Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins down regulate both DC-SIGN and DC-SIGNR. Lang SM; Bynoe MO; Karki R; Tartell MA; Means RE PLoS One; 2013; 8(2):e58056. PubMed ID: 23460925 [TBL] [Abstract][Full Text] [Related]
7. Contribution of the Cytoplasmic Determinants of Vpu to the Expansion of Virus-Containing Compartments in HIV-1-Infected Macrophages. Leymarie O; Lepont L; Versapuech M; Judith D; Abelanet S; Janvier K; Berlioz-Torrent C J Virol; 2019 Jun; 93(11):. PubMed ID: 30867316 [TBL] [Abstract][Full Text] [Related]
8. Importance of accessibility to the extracellular juxtamembrane stalk region of membrane protein for substrate recognition by viral ubiquitin ligase K5. Kajikawa M; Hata M; Ishimura M; Imaizumi N; Kimura M; Miyano K; Ose T; Asai D; Ishido S; Kanamoto T Biochem J; 2022 Oct; 479(20):2261-2278. PubMed ID: 36305710 [TBL] [Abstract][Full Text] [Related]
9. BST2/Tetherin enhances entry of human cytomegalovirus. Viswanathan K; Smith MS; Malouli D; Mansouri M; Nelson JA; Früh K PLoS Pathog; 2011 Nov; 7(11):e1002332. PubMed ID: 22072961 [TBL] [Abstract][Full Text] [Related]
10. Kaposi sarcoma herpesvirus K5 removes CD31/PECAM from endothelial cells. Mansouri M; Douglas J; Rose PP; Gouveia K; Thomas G; Means RE; Moses AV; Früh K Blood; 2006 Sep; 108(6):1932-40. PubMed ID: 16601245 [TBL] [Abstract][Full Text] [Related]
11. HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. Mangeat B; Gers-Huber G; Lehmann M; Zufferey M; Luban J; Piguet V PLoS Pathog; 2009 Sep; 5(9):e1000574. PubMed ID: 19730691 [TBL] [Abstract][Full Text] [Related]
12. Role of the endosomal ESCRT machinery in HIV-1 Vpu-induced down-regulation of BST2/tetherin. Janvier K; Roy N; Berlioz-Torrent C Curr HIV Res; 2012 Jun; 10(4):315-20. PubMed ID: 22524180 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Ishido S; Choi JK; Lee BS; Wang C; DeMaria M; Johnson RP; Cohen GB; Jung JU Immunity; 2000 Sep; 13(3):365-74. PubMed ID: 11021534 [TBL] [Abstract][Full Text] [Related]
14. Membrane Anchoring by a C-terminal Tryptophan Enables HIV-1 Vpu to Displace Bone Marrow Stromal Antigen 2 (BST2) from Sites of Viral Assembly. Lewinski MK; Jafari M; Zhang H; Opella SJ; Guatelli J J Biol Chem; 2015 Apr; 290(17):10919-33. PubMed ID: 25759385 [TBL] [Abstract][Full Text] [Related]
15. Downregulation of gamma interferon receptor 1 by Kaposi's sarcoma-associated herpesvirus K3 and K5. Li Q; Means R; Lang S; Jung JU J Virol; 2007 Mar; 81(5):2117-27. PubMed ID: 17166914 [TBL] [Abstract][Full Text] [Related]
16. Major histocompatibility complex class I molecules are down-regulated at the cell surface by the K5 protein encoded by Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Haque M; Ueda K; Nakano K; Hirata Y; Parravicini C; Corbellino M; Yamanishi K J Gen Virol; 2001 May; 82(Pt 5):1175-1180. PubMed ID: 11297692 [TBL] [Abstract][Full Text] [Related]
17. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism. Douglas JL; Viswanathan K; McCarroll MN; Gustin JK; Früh K; Moses AV J Virol; 2009 Aug; 83(16):7931-47. PubMed ID: 19515779 [TBL] [Abstract][Full Text] [Related]
18. Haploid genetic screens identify an essential role for PLP2 in the downregulation of novel plasma membrane targets by viral E3 ubiquitin ligases. Timms RT; Duncan LM; Tchasovnikarova IA; Antrobus R; Smith DL; Dougan G; Weekes MP; Lehner PJ PLoS Pathog; 2013; 9(11):e1003772. PubMed ID: 24278019 [TBL] [Abstract][Full Text] [Related]
19. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. Ishido S; Wang C; Lee BS; Cohen GB; Jung JU J Virol; 2000 Jun; 74(11):5300-9. PubMed ID: 10799607 [TBL] [Abstract][Full Text] [Related]
20. A basic charge cluster near the C-terminus of the cytoplasmic tail contributes to the molecular stability of human herpesvirus 8 E3 ubiquitin ligases. Kajikawa M; Kato K; Takahashi H; Kitajima S; Kusunoki Y; Haga M; Kimura M; Inoue Y; Miyano K; Kanamoto T Microbiol Immunol; 2023 Jun; 67(6):293-302. PubMed ID: 37067224 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]